The absence of voiding symptoms in men with a PSA ≥ 3.0 ng / mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening Trial

Por Frånlund, Maria, Carlsson, Sigrid, Stranne, Johan, Aus, Gunnar, Hugosson, Jonas
Publicado no BJU Int (2012)

Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial

Por Bergdahl, Anna Grenabo, Wilderäng, Ulrica, Aus, Gunnar, Carlsson, Sigrid, Damber, Jan-Erik, Frånlund, Maria, Geterud, Kjell, Khatami, Ali, Socratous, Andreas, Stranne, Johan, Hellström, Mikael, Hugosson, Jonas
Publicado no Eur Urol (2015)